Dawn Halkuff - Net Worth and Insider Trading
Dawn Halkuff Net Worth
The estimated net worth of Dawn Halkuff is at least $277,433 dollars as of 2025-04-29. Dawn Halkuff is the Director of Xeris Biopharma Holdings Inc and owns about 62,910 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $277,433. Details can be seen in Dawn Halkuff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dawn Halkuff has not made any transactions after 2023-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dawn Halkuff
Dawn Halkuff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dawn Halkuff owns 1 companies in total, including Xeris Biopharma Holdings Inc (XERS) .
Click here to see the complete history of Dawn Halkuff’s form 4 insider trades.
Insider Ownership Summary of Dawn Halkuff
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-11-20 | director |
Dawn Halkuff Latest Holdings Summary
Dawn Halkuff currently owns a total of 1 stock. Dawn Halkuff owns 62,910 shares of Xeris Biopharma Holdings Inc (XERS) as of November 20, 2023, with a value of $277,433.
Latest Holdings of Dawn Halkuff
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-11-20 | 62,910 | 4.41 | 277,433 |
Holding Weightings of Dawn Halkuff
Dawn Halkuff Form 4 Trading Tracker
According to the SEC Form 4 filings, Dawn Halkuff has made a total of 1 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 5,410 shares on November 20, 2023, which cost Dawn Halkuff around $9,954.
Insider Trading History of Dawn Halkuff
- 1
Dawn Halkuff Trading Performance
GuruFocus tracks the stock performance after each of Dawn Halkuff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dawn Halkuff is 73.63%. GuruFocus also compares Dawn Halkuff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dawn Halkuff within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dawn Halkuff's insider trading performs compared to the benchmark.
Performance of Dawn Halkuff
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.44 | | | | | |
| Relative Return to S&P 500(%) | 7.12 | | | | | |
Dawn Halkuff Ownership Network
Ownership Network List of Dawn Halkuff
Ownership Network Relation of Dawn Halkuff
Dawn Halkuff Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Dawn Halkuff is the director of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include See Remarks Beth Hecht , Chief Financial Officer Steven Pieper , and See Remarks Shannon John Patrick Jr .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Dawn Halkuff made 1 insider transaction in Xeris Biopharma Holdings Inc (XERS) with a net purchase of 5,410. Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net sale of 40,000 shares made by Beth Hecht , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .
In summary, during the past 3 months, insiders sold 40,000 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 40,000 shares. During the past 18 months, 40,000 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 94,779 shares were bought by its insiders, resulting in a net purchase of 54,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Dawn Halkuff Mailing Address
Above is the net worth, insider trading, and ownership report for Dawn Halkuff. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Dawn Halkuff's mailing address is: Chicago Il 60601.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
